ArticleCell death & disease2021

The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer.

Christopher E Eyermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.